Clinical Trial Update: Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the therapeutic effect of nerve growth factor (mNGF) for cognitive decline in cerebral small vessel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Diseases

Drugs mentioned

• mNGF (nerve growth factor)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Cerebral Small Vessel Diseases | Phase 4 | Status: UNKNOWN